Stuart Duty - 16 Oct 2023 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
16 Oct 2023
Net transactions value
$0
Form type
4
Filing time
17 Oct 2023, 16:49:33 UTC
Previous filing
30 Mar 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Option (Right to Buy) Award $0 +60,000 $0.000000 60,000 16 Oct 2023 Common Stock 60,000 $8.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in three ratable annual installments beginning on October 16, 2024.